(NASDAQ: RMTI) Rockwell Medical's forecast annual revenue growth rate of -28.58% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 1.46%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 54.43%.
Rockwell Medical's revenue in 2025 is $97,727,000.On average, 1 Wall Street analysts forecast RMTI's revenue for 2025 to be $2,385,393,153, with the lowest RMTI revenue forecast at $2,385,393,153, and the highest RMTI revenue forecast at $2,385,393,153.
In 2026, RMTI is forecast to generate $2,754,479,772 in revenue, with the lowest revenue forecast at $2,754,479,772 and the highest revenue forecast at $2,754,479,772.